Answer
Women of childbearing potential should use effective contraception throughout Lagevrio (molnupiravir) treatment and for 4 days after the last dose.
Sources for this answer
- Lagevrio 200 mg hard capsulesMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked